Clinical Trial

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Study acronym: GLP1-TASTE
Recruiting
View on ClinicalTrials.gov →
Summary
This observational retrospective study aims to evaluate changes in taste perception, eating habits, and behavioral aspects in adults treated with GLP-1 receptor agonists for weight loss. Participants include adults aged 18-60 receiving treatment at specialized nutrition centers in Italy. Data are collected from clinical records, dietary questionnaires, and metabolic assessments before and after at least 12 weeks of GLP-1 agonist treatment. The study's primary goal is to understand how these treatments affect food preferences and taste perception. Secondary outcomes include changes in body weight, body composition, gastrointestinal side effects, and treatment adherence. All data are anonymized and collected according to ethical guidelines.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-13.
Status change: Not Yet Recruiting → Recruiting 2026-04-22
Trial Details
NCT Number NCT07229170
Lead Sponsor San Raffaele Telematic University
Conditions Obesity & Overweight, Taste Alterations, Weight Loss, Eating Behavior Changes
Enrollment 150 participants
Start Date 2025-12-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-28